Stephen Bloch, MD

Stephen Bloch, MD is a General Partner at Canaan Partners, where he invests across seed to late-stage ventures in biopharma, digital health, medical devices, and diagnostics. He invests primarily in the United States, including the Northeast (East Coast, New England, Connecticut). He serves on the board of Liquidia Corporation and has invested in companies like Liquidia Corporation, Advanced BioHealing, Amicus Therapeutics, Marinus Pharmaceuticals, and Ambra Health. Before Canaan, he was Chief Executive Officer of Radiology Management Sciences and a consultant at Arthur D. Little. Stephen studied at the University of Rochester School of Medicine and Dentistry and resides in the United States.